Table 1: Demographic, clinical and serological data of the studied groups.
Parameters |
RA patients |
Healthy controls |
P value |
Gender (female no. & %) |
75(90.4%) |
18 (90%) |
NS* |
Age(year) |
37.59±8.35 |
36.07±7.71 |
NS |
BMI(kg/m2) |
28.22±6.49 |
29.15±4.64 |
NS |
Disease duration(month) |
38.38±16.77 |
----- |
--- |
ESR(mm/hour) |
40.07± 23.04 |
14.55±7.85 |
0.000 |
CRP(mg/dl) |
14.98± 19.42 |
2.60± 0.79 |
0.005 |
RF(IU/dl) |
53.14 ± 57.16 |
9.95± 3.28 |
0.001 |
ACPA(U/dl) |
24.74± 29.84 |
2.59± 1.23 |
0.001 |
ESM1(pg./ml) |
2652.25±2803.40 |
546.74±181.64 |
0.000 |
DAS28 score |
3.69±1.19 |
----------------- |
--------- |
HAQ-DI |
1.36±1.12 |
------------------- |
---------- |
Modified Larsen score |
1.66±1.04 |
-------------------- |
----------- |
BMI = Body Mass Index, ESR = Erythrocyte Sedimentation Rate, CRP = C Reactive Protein, RF = Rheumatoid Factor, ACPA = Anti-Citrullinated Peptide Antibody, ESM-1 = Endothelial Cell Specific Molecule 1, DAS = Disease Activity Score. *= Chi- Square test, HAQ-DI = The Health Assessment Questionnaire Disability Index.